RETA INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Reata Pharmaceuticals, Inc.

Posted on by

NEW YORK, June 1, 2023 /PRNewswire/ — Levi & Korsinsky notifies investors that it has commenced an investigation of Reata Pharmaceuticals, Inc. (“Reata”) (NASDAQ: RETA) concerning possible violations of federal securities laws. On May 10, 2023, Reata issued a press release announcing its…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.